Information About Fosamax Off-Label Use

Fosamax Lawsuit
Every year, more than 20 million prescriptions are written for Fosamax, the leading medication to treat several disease of the bone. Due to the increase in the number of people complaining and filing lawsuits because of the drug and its reported adverse effects like femur fractures and osteonecrosis of the jaw (ONJ), there is now a need for consumers to be more careful. This is the reason why DEXA scanning is advised to lessen Fosmax femur fracture risk.


Fosamax belongs to a class of drug called biphosphonates, which acts on the body by changing the cycle halting bone resorption that consequently increases bone mass. Doctors have been authorized by the Food and Drug Administration (FDA) to give Fosamax, alendronate sodium, to its patients to prevent or treat osteoporosis in both men and women. This medicine is also used to treat people afflicted with Paget’s Disease. Also, your doctor may order you to take the drug for indications not authorized by the FDA when your medical condition requires such treatment.

Using the drug for an indication, dosage, or form on administration that which has not been accredited by the FDA is regarded as off-label. Doctors have found out that Fosamax may be given to treat cancers that have affects the bone structures. This cancers include lung, breast, multiple myeloma and prostate cancers. More off-label use of the drug includes vitamin D overdose treatment as well as osteoporosis resulting from a spinal injury.

Significant weight loss is one of the side effects of biphosphonate that appears to be very appealing to some young adults. Even so, taking the drug in order to drop some weight may be inappropriate because it entails more danger. Consult your doctor and be advised on what medication is more appropriate for you to lose weight.

The use of the drug for unauthorized indication, especially if not ordered by your physician, may yield unwanted problems to your health. Some of its side effects include ulcerations and bleeding in the esophagus and, in rare occasions, the death of a jaw bone tissue (osteonecrosis of the jaw). Recently, there have been increasing data suggesting that the long-term use of the drug may bring about an atypical form of Fosamax femur fracture. Enduring a Fosamax side effect that Merck, the company behind Fosamax, did not reveal to the public may be a good reason for filing a lawsuit However, your compensatory lawsuit might be compromised if you are taking the drug for an off-label use. It is important to always be careful.

References:

http://www.npr.org/templates/story/story.php?storyId=121609815
http://www.capecodonline.com/apps/pbcs.dll/article?AID=/20111229/LIFE/112290301/-1/LIFE03